Serum Diagnosis of Pancreatic Adenocarcinoma Using Surface-Enhanced Laser Desorption and Ionization Mass Spectrometry

Clinical Cancer Research

Volumn 10, Issue 3, 2004, Pages 860-868

  Koopmann, Jens ^a   Zhang, Zhen ^a   White, Nicole ^a   Rosenzweig, Jason ^a   Fedarko, Neal ^a   Jagannath, Sanjay ^a   Canto, Marcia I ^a   Yeo, Charles J ^a   Chan, Daniel W ^a   Goggins, Michael ^a  

^a DEPARTMENT OF PATHOLOGY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CA 19-9 ANTIGEN; PROTEIN; TUMOR MARKER;

ADVANCED CANCER; AGE DISTRIBUTION; ANION EXCHANGE; ARTICLE; CANCER MORTALITY; CANCER SURGERY; CANCER SURVIVAL; CASE CONTROL STUDY; CATION EXCHANGE; CELL DIFFERENTIATION; CONTROLLED STUDY; DIAGNOSTIC ACCURACY; DIFFERENTIAL DIAGNOSIS; DNA FINGERPRINTING; DNA MICROARRAY; EARLY DIAGNOSIS; FEMALE; GENDER; HUMAN; HUMAN CELL; HUMAN TISSUE; MAJOR CLINICAL STUDY; MALE; MASS SPECTROMETRY; METAL BINDING; PANCREAS ADENOCARCINOMA; PANCREATITIS; PATIENT SELECTION; PRIORITY JOURNAL; PROGNOSIS; PROTEIN ANALYSIS; SAMPLING; SENSITIVITY AND SPECIFICITY; SEPARATION TECHNIQUE; SERODIAGNOSIS; SURFACE ENHANCED LASER DESORPTION AND IONIZATION MASS SPECTROMETRY; UNITED STATES;

ADENOCARCINOMA; ALGORITHMS; ANIONS; CA-19-9 ANTIGEN; CASE-CONTROL STUDIES; CHROMATOGRAPHY, ION EXCHANGE; ENZYME-LINKED IMMUNOSORBENT ASSAY; FEMALE; HUMANS; LASERS; MALE; MASS SPECTROMETRY; PANCREATIC NEOPLASMS; PROTEIN ARRAY ANALYSIS; REGRESSION ANALYSIS; SENSITIVITY AND SPECIFICITY;

EID: 10744223905     PISSN: 10780432     EISSN: None     Source Type: Journal    
DOI: 10.1158/1078-0432.CCR-1167-3     Document Type: Article

References (35)

1. DiMagno, E. P., Reber, H. A., and Tempero, M. A. Epidemiology, diagnosis, and treatment of pancreatic ductal adenocarcinoma. Gastroenterology, 117: 1463-1484, 1999.
2. Jemal, A., Murray, T., Samuels, A., Ghafoor, A., Ward, E., and Thun, M. J. Cancer statistics 2003. CA Cancer J. Clin., 53: 5-26, 2003.
3. Yeo, C. J., Cameron, J. L., Lillemoe, K. D., and Sitzmann, J. V. Pancreaticoduodenectomy for cancer of the head of the pancreas:201 patients. Ann. Surg., 221: 721-731, 1995.
4. Rosty, C., and Goggins, M. Early detection of pancreatic carcinoma. Hematol. Oncol. Clin. North Am., 16: 37-52, 2002.
5. Smith, R. A., Cokkinides, V., and Eyre, H. J. American Cancer Society guidelines for the early detection of cancer 2003. CA Cancer J. Clin., 53: 27-43, 2003.
6. Tersmette, A. C., Petersen, G. M., Offerhaus, G. J. A., Falatko, F. C., Brune, K., Goggins, M., Rozenblum, E., Wilentz, R. E., Yeo, C. J., Cameron, J. L., Kern, S. E., and Hruban, R. H. Increased risk of pancreatic cancer among first-degree relatives of patients with familial pancreatic cancer. Clin. Cancer Res., 7: 738-744, 2001.
7. Giardiello, F. M., Brensinger, J. D., Tersmette, A. C., Goodman, S. N., Petersen, G. M., Boozer, S. V., Cruz-Correa, M., and Offerhaus, G. J. A. Very high risk of cancer in familial Peutz-Jeghers syndrome. Gastroenterology, 119: 1447-1453, 2000.
8. Lowenfels, A. B., Maisonneuve, P., DiMagno, E. P., Elitsur, Y., Gates, L. K. J., Perrault, J., and Whitcomb, D. C. Hereditary pancreatitis and the risk of pancreatic cancer. International Hereditary Pancreatitis Study Group. J. Natl. Cancer Inst., 89: 442-446, 1997.
9. Pleskow, D. K., Berher, H. J., Gyves, J., Allen, E., McLean, A., and Podolsky, D. K. Evaluation of a serologic marker, CA19-9, in the diagnosis of pancreatic cancer. Ann. Intern. Med., 110: 704-709, 1989.
10. Goggins, M., Canto, M., and Hruban, R. H. Can we screen high-risk individuals to detect early pancreatic carcinoma? J. Surg. Oncol., 74: 243-248, 2000.
11. Weinberger, S. R., Dalmasso, E. A., and Fung, E. T. Current achievements using ProteinChip Array technology. Curr. Opin. Chem. Biol., 6: 86-91, 2002.
12. Srinivas, P. R., Verma, M., Zhao, Y., and Srivastava, S. Proteomics for cancer biomarker discovery. Clin. Chem., 48: 1160-1169, 2002.
13. Hanash, S. M. Disease proteomics. Nature (Lond.), 422: 226-232, 2003.
14. Chen, G., Gharib, T. G., Huang, C. C., Thomas, D. G., Shedden, K. A., Taylor, J. M., Kardia, S. L., Misek, D. E., Giordano, T. J., Iannettoni, M. D., Orringer, M. B., Hanash, S. M., and Beer, D. G. Proteomic analysis of lung adenocarcinoma: identification of a highly expressed set of proteins in tumors. Clin. Cancer Res., 8: 2298-2305, 2002.
15. Iacobuzio-Donahue, C. A., Maitra, A., Shen-Ong, G. L., Van Heek, T., Ashfaq, R., Meyer, R., Walter, K., Berg, K., Hollingsworth, M. A., Cameron, J. L., Yeo, C. J., Kern, S. E., Goggins, M., and Hruban, R. H. Discovery of novel tumor markers of pancreatic cancer using global gene expression technology. Am. J. Pathol., 160: 1239-1249, 2002.
16. Iacobuzio-Donahue, C. A., Maitra, A., Olsen, M., Lowe, A. W., van Heek, N. T., Rosty, C., Walter, K., Sato, N., Parker, A., Ashfaq, R., Jaffee, E., Ryu, B., Jones, J., Eshleman, J. R., Yeo, C. J., Cameron, J. L., Kern, S. E., Hruban, R. H., Brown, P. O., and Goggins, M. Exploration of global gene expression patterns in pancreatic adenocarcinoma using cDNA microarrays. Am. J. Pathol., 162: 1151-1162, 2003.
17. Welsh, J. B., Sapinoso, L. M., Kern, S. G., Brown, D. A., Liu, T., Bauskin, A. R., Ward, R. L., Hawkins, N. J., Quinn, D. I., Russell, P. J., Sutherland, R. L., Breit, S. N., Moskaluk, C. A., Frierson, H. F. J., and Hampton, G. Large-scale delineation of secreted protein biomarkers overexpressed in cancer tissue and serum. Proc. Natl. Acad. Sci. U S A, 100: 3410-3415, 2003.
18. Petricoin, E. F., Ardekani, A. M., Hitt, B. A., Levine, P. J., Fusaro, V. A., Steinberg, S. M., Mills, G. B., Simone, C., Fishman, D. A., Kohn, E. C., and Liotta, L. A. Use of proteomic patterns in serum to identify ovarian cancer. Lancet, 359: 572-577, 2002.
19. Rai, A. J., Zhang, Z., Rosenzweig, J., Shih, I-M., Pham, T., Fung, E. T., Sokoll, L. J., and Chan, D. W. Proteomic approaches to tumor marker discovery. Arch. Pathol. Lab. Med., 126: 1518-1526, 2002.
20. Li, J., Zhang, Z., Rosenzweig, J., Wang, Y. Y., and Chan, D. W. Proteomics and bioinformatics approaches for identification of serum biomarkers to detect breast cancer. Clin. Chem., 48: 1296-1304, 2002.
21. Adam, B., Qu, Y., Davis, J., Ward, M., Clements, M., Cazares, L., Semmes, O., Schellhammer, P., Yasui, Y., Feng, Z., and Wright, G. J. Serum protein fingerprinting coupled with a pattern-matching algorithm distinguishes prostate cancer from benign prostate hyperplasia and healthy men. Cancer Res., 62: 3609-3614, 2002.
22. Petricoin, E. F., Ornstein, D. K., Paweletz, C. P., Ardekani, A., Hackett, P. S., Hitt, B. A., Velassco, A., Trucco, C., Wiegand, L., Wood, K., Simone, C. B., Levine, P. J., Linehan, W. M., Emmert-Buck, M. R., Steinberg, S. M., Kohn, E. C., and Liotta, L. A. Serum proteomic patterns for detection of prostate cancer. J. Natl. Cancer Inst., 94: 1576-1578, 2002.
23. Poon, T. C., Yip, T. T., Chan, A. T., Yip, C., Yip, V., Mok, T. S., Lee, C. C., Leung, T. W., Ho, S. K., and Johnson, P. J. Comprehensive proteomic profiling identifies serum proteomic signatures for detection of hepatocellular carcinoma and its subtypes. Clin. Chem., 49: 752-760, 2003.
24. Vlahou, A., Schellhammer, P. F., Mendrinos, S., Patel, K., Kondylis, F. I., Gong, L., Nasim, S., and Wright, J. G. L. Development of a novel proteomic approach for the detection of transitional cell carcinoma of the bladder in urine. Am. J. Pathol., 158: 1491-1502, 2001.
25. Rosty, C., Christa, L., Kuzdzal, S., Baldwin, W. M., Zahurak, M. L., Chan, D. W., Canto, M., Lillemoe, K. D., Cameron, J. L., Yeo, C. J., Hruban, R. H., and Goggins, M. Identification of hepatocarcinoma-intestine-pancreas/pancreatitis-associated protein I as a biomarker fot pancreatic ductal adenocarcinoma by protein biochip technology. Cancer Res., 62: 1868-1875, 2002.
26. Valerio, A., Basso, D., Mazza, S., Baldo, G., Tiengo, A., Pedrazzoli, S., Seraglia, R., and Plebani, M. Serum protein profiles of patients with pancreatic cancer and chronic pancreatitis: searching for a diagnostic protein pattern. Rapid Commun. Mass. Spectrom., 15: 2420-2425, 2001.
27. Fung, E. T., and Enderwick, C. ProteinChip clinical proteomics: computational challenges and solutions. Biotechniques, (Suppl. 3): 34-38, 40-41, 2002.
28. Boguski, M. S., and McIntosh, M. W. Biomedical informatics for proteomics. Nature (Lond.), 422: 233-237, 2003.
29. Kanehisa, M., and Bork, P. Bioinformatics in the post-sequence era. Nat. Genet., 33: 305-310, 2003.
30. Zhang, Z., Page, G., and Zhang, H. Applying Classification Separability Analysis to Microarray Data. In: Lin, S. M., Johnson, K. F. (eds). Methods of Microassay Data Analysis: Papers from CAMDA '00, pp. 25-26. Boston: Kluwer Academic Publishers, 2001.
31. Anderson, N. L., and Anderson, N. G. The human plasma proteome: history, character, and diagnostic prospects. Mol. Cell Proteomics, 1: 845-867, 2003.
32. Iacobuzio-Donahue, C. A., Ryu, B., Hruban, R. H., and Kern, S. E. Exploring the host desmoplastic response to pancreatic carcinoma. Am. J. Pathol., 160: 91-99, 2002.
33. Ryu, B., Jones, J., Blades, N. J., Parmigiani, G., Hollingsworth, M. A., Hruban, R. H., and Kern, S. E. Relationships and differentially expressed genes among pancreatic cancers examined by large-scale serial analysis of gene expression. Cancer Res., 62: 819-926, 2002.
34. Fukushima, N., Walter, K. M., Ueki, T., Sato, N., Matsubayashi, H., Cameron, J. L., Hruban, R. H., Canto, M., Yeo, C. J., and Goggins, M. Diagnosing pancreatic cancer using methylation specific PCR analysis of pancreatic juice. Cancer Biol. Ther., 2: 78-83, 2003.
35. Brentnall, T. A., Bronner, M. P., Byrd, D. R., Haggitt, R. C., and Kimmey, M. B. Early diagnosis and treatment of pancreatic dysplasia in patients with a family history of pancreatic cancer. Ann. Intern. Med., 131: 247-255, 1999.